lenses. quarterly center. great by with to revenue I'm our progress challenges distribution quarter and pleased operational hydrogel of Kim, U.S. And welcome, driven today's organization. you, everyone, CooperSurgical posted CooperVision impacting to solid report our unexpected despite portfolio growth, a silicone system call. some record the revenues, leading Thank upgrade returned our double-digit throughout to
and activity, growth. leverage prior Margins as we investment earnings delivered improved we excellent
As momentum forward, our and increasing earnings and incorporating revenue seeing the guidance our we're move markets. by quarter we in this past
the details of record ] X% led $XXX improved an percentages earnings million, CooperSurgical on posted quarterly [ by posted million, revenues basis. up of and revenues $XXX to up Moving all our Margins a XX%, silicone non-GAAP hydrogel Consolidated and year, were record quarterly $XXX reporting share per up X%. CooperVision a million, and were organic portfolio, revenues $X.XX. daily
XX% accounts. and All combined For CooperVision, innovative led by were Within the X%. key market-leading XX% XX%, regions portfolios, X%. and torics strength X EMEA in and categories, flexibility up spheres and Americas were Pac, grew grow multifocals our Asia product to
XX%, modalities, up MyDay Avaira strength focused our around Biofinity the clariti, was our silicone our our combined silicone grew portfolio. myopia growing with very FRP and quarter XX%. All And management world product daily MiSight and lenses, in, a portfolio hydrogel to hydrogel lenses throughout XX%. and grow nice XX%, Within with
is another growing order With our to our success details leading products. the penta market MyDay outstanding category. delivering with every toric with Turning and way, MyDay high-growth in multifocal and particular [ hydrogel starting silicone portfolio, add we ] results. innovative daily every and product in
the fit range, which Europe expansion in daily parameter SKU eye the by industry-leading widest in market. and professionals toric across range and North more design is ECP or America toric market-leading enabling launch care ongoing our to is Our far wearers
including high a satisfaction advanced resulted combination levels, in paired In of a system very MyDay success multifocal an unique or is rate in design less. fit two XX% fitting easy [ multifocal with ] has an
of an market. a continue contact doubt to best fantastic it on myself count in to receive wearer the ecstatic multifocal the lens continue lens, without We feedback what I as very is positive and
Energys showing product, our We've also very especially growth. strong seen success which with spears, is with our MyDay
is to lifestyle important and digital improvement lens and Energys innovative meaningful the is wearers this by technology its technological today's boost contact for digital specifically ECPs. designed driven
the Given in the strong in it performance future. of business in near the to excited U.S., markets additional we're launch
clariti. to Moving
Our our for comfort, family a silicone this which updating love a lenses legacy other driver especially continues driver. success of base daily wearers. good it wearers. and also wearer with remains handed product for easy hydrogel in hydrogel ECPs an makes of complete be It affordability, noted its new choice to expanding daily
expanding and has toward very healthy. and fantastic dailies, XX.X% markets and accomplishment successful. multifocals require an incredible is lenses torics most availability of expanding of the types new reasons and lines fit Outside markets we'll now This benefit prescriptions. who ECPs patient ranges of one traditional patients made-to-order the vision in now be for in to into and new the manufacturing Energys Biofinity in near portfolio lenses, to and continued the This ability provides remains so these With beyond The launching demand office complex remains amazing spheres, differentiator in of true of a a any of manufacturing future. multifocals, service, those Avaira Biofinity Biofinity correction. in ranges state-of-the-art expanded and the an is
Moving to myopia traction, MiSight management. demand. powered gain continues healthy by to
Americas reported Asia month record April. was posted record and a quarter, a Pac strong EMEA in the
reduction quarter. by channel were inventory a in the negatively revenues Although during impacted
robust here. results promotional saw we we expect soon the based back-to-school success on campaigns Our and are starting
So this strong in expecting we're year. back the results of half
In clinical the the XX-year XXXX which from gold control study of duration Pivotal the trial anniversary longest MiSight the children. first running This a control. and in intervention clinical myopia in and contact study lens wear marking being to trial anniversary optical MiSight the with meantime, we're led a FDA-approved of for becoming still in remains from standard the X-day design MiSight study milestone only myopia
control initiatives to be can quarter. establishing CooperVision's this via X seen commitment important of and myopia continues launched care standard
available to the help to interactive practical myopia of offices ECPs tool and of navigator part Optometry, their around partnership This practices. exclusive provides with tips management we've World the myopia as our at digital world. the a resources of management into First, launched continuation toolkit Council
Second, ECPs management Association to care U.S. groundbreaking collective a their CooperVision myopia to as have Optometric of rally American and the partnered for standard adopt pediatric initiative the myopia on the program XX of a The AOA and recruiting is to for District patients. and the policy state each who plus CooperVision with community Columbia work advocate ECPs currently proactively will change. representing
the conclude in contact grew calendar To roughly X%. with share our taking X% lenses, market Cooper QX,
new long-term We products, in fast-growing we our continue portfolio, robust positive data. to this, innovation, to market myopia driven several within with expect leading product management business growth And forward, trends. moving a premium launches, a remain leader expect strength robust by product ongoing macro fit and
reach quarterly fertility million, in X%. cost up strong, our was $XXX this We manage but largely PARAGARD, we're able in and CooperSurgical. the our and We center overcome a backlog systems organic posted revenues distribution Demand progress, range, medical comfortable entirely. to upgrade full were to revenue not and products. U.S. Having but of said strength for device of Moving shipping interruptions unchanged. guidance which we'll lot year we've that, a our made remains
data. experience operations upgrades IT growth, it more certainly of Implementing supports effective improved challenging, our real-time makes work internal success better can a to infrastructure be efficient is customer and long-term but creates type critical with as this
Moving to Sales million, X%. fertility. up were $XXX
look to world facilities, leading also locations for services open strong and well We new with providing to future, of continue donor new products operations. around they improve extensive outcomes our the our existing opportunities geographically and continuing centers demand excellence, our training and upgrade for us investing the opening expanding We're innovation. accelerating clinics optimize in sites, and with position seeing as fertility
This investing on delivering media. focus remains only unmatched. innovative advanced and European clinics Our fertility solutions and and the the a approval formulated for includes to first and uniquely patients most one-step
improved sustained communication and implementation and culture embryo media development, specialized [ transfer no embryo Embryo This and reinforces pregnancy. ] for
the journey our genetic testing, but fertility-based science advances we're the providing types to we're to parenthood. of commitment delivering this is goal improve and these work. market-leading to this Similar to it's straightforward, continue and type Developing is making the innovations a the leader of complex, why innovative, technologies in space, is in
including industry, patient macro Health in people fertility at broader point highlights advancements improving by in their in the awareness, dynamic several positive lives. access technology will benefits The increasing that affected childbirth, infertility X greater by delaying and treatment. X some supported World Regarding is to be coverage, growth market trends, Organization this
this impacts is of people, an we'll future. a the that lot issue in So and do so
we this to patients and incredibly remain industry advancing innovative products, global access committed a a on space, delivering in support in leader the to improving treatment by clinics As basis. to standing and
with driven sales our posted up and challenges. to was $XXX [ to X% babies XX%. And demand demand products by devices led medical due healthy, ] the of mentioned our obstetrics was ally shipping we the portfolio devices, most declining the our up PARAGARD labor Devices, now up delivery of X% previously uterine and strong. storage portfolio. Stem surgical X% arguably is gynecological medical cell comprehensive of safety Medical by and CooperSurgical minimally mothers Within million, and Moving portfolio ensuring manipulator remains invasive
the Our will in stem related to largely Destocking expectations naturally of a quarter with price PARAGARD itself benefit cell and mid-single-digit outperformed had increase. stocking business fiscal a solid offset QX.
special. services, that roughly on and We're a world, can impact obstetrics using and lives, in making baby now with of global the conclude a say people's products our somewhere CooperSurgical and update may every is seconds, CooperSurgical, very business to portfolio we our born the To expand that community around XX products. difference
let It's you responsibility sustainability, wrap we social reading up, website ESG efforts add chance. which when corporate report, strong environmental me that corporate latest on and our To our our released what and just a around have highlights governance.
our for commitment way. and about things to I'm to We doing employees are world the sustainability, passionate around thankful right the their
you drive hard employees that, turn work continuing the let over to dedication Brian. thank So and their as And success. call XX,XXX-plus with to they for our now say our I'll me